Spectral Computed Tomography (CT) Market Technological Advancement - 2022 Evolution Growth Opportunities, Industry Revenue Analysis by MRFR

The global spectral computed tomography (CT) market is growing mainly due to rising cases of chronic diseases. According to a recent study report published by the Market Research Future, the global Spectral Computed Tomography (CT) market is booming and expected to gain prominence over the forecast period. The market is forecast to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Computed Tomography is an imaging technique that uses x-rays to form pictures of the inside of the body. CT scan has ability to create pictures of internal anatomy and convert them to film through diagnostic imaging, which has changed the diagnostic and treatment of many diseases. Spectral computed tomography (CT) is an advanced form of CT with increasing applications in head and neck radiology.

Browse Premium Sample Copy of 80 Premium Pages Report Enabled with Competitive Analysis of Niche Segments, Top Players, Comprehensive Research and Key Regions @ https://www.marketresearchfuture.com/sample_request/1026

Notably, the rising prevalence of chronic diseases, such as cancer, neurological diseases, cardiovascular diseases, chronic pain, orthopaedic diseases, and others, is one of the most prominent factors driving spectral computed tomography (CT) market. As per the study published in Pain Research and Management in 2017, the prevalence of chronic pain among Brazilian population was 39%, 31.7% in the French population, 48% in UK, and 50% in England.

Key Players for Global Spectral Computed Tomography (CT) Market

Market Research Future (MRFR) recognizes the following companies as the key players in Spectral Computed Tomography (CT) Market: There are plenty of large and small market players which operate in this market all over the globe.

CANON MEDICAL SYSTEMS CORPORATION (Japan), General Electric Company (U.S.), Hitachi Medical Systems (U.S.), iCAD, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp. (U.S.), Neusoft Medical Systems (China), PerkinElmer Inc. (U.S.), Shenzhen Anke High-tech Co., Ltd. (China), Shimadzu Corporation (Japan), Siemens Corporation (U.S.), Thermo Fisher Scientific (U.S.), Trivitron Healthcare (India), Varian Medical Systems, Inc. (U.S.), Xoran Technologies, LLC. (U.S.), and others are some of the prominent players at the forefront of competition in the spectral computed tomography (CT) market and are profiled in MRFR Analysis.

Spectral Computed Tomography (CT) Market - Competitive Analysis

Global Spectral Computed Tomography (CT) Market - Competitive Analysis

The Spectral Computed Tomography (CT) market is currently dominated by numerous players.

Koninklijke Philips N.V. is one of them by holding a major share in the Spectral Computed Tomography (CT) market. The company offers magnetic resonance imaging, diagnostic imaging solutions, computed tomography, and diagnostic X-ray. In November 2016, Philips launched Philips IQon Spectral CT in Canada. The Philips IQon Spectral CT is the spectral detector CT which is specifically designed for spectral imaging. The product delivers on-demand colour quantification with an ability to characterize structures simply at a low dose.

Siemens Healthcare GmbH is another renowned market player in the market. The company provides medical diagnostics solutions, healthcare equipment, and related services. Siemens offers products and solutions in the areas of laboratory diagnostics, healthcare IT, hearing instruments, and infrastructure, refurbished systems, and education and training, medical accessories, electronics, and others.

Strategic partnership is an essential part of Siemen’s strategy to reach its goal of new products pipeline, by accruing partner’s technology, and products. For instance, in December, 2017, Siemens Healthineers has entered an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD). With the help of this acquisition, Siemens now include FTD's sites in Luxembourg, India, and Malta along with its workforce of about 80 employees.

General Electric Company is a leading provider of medical imaging equipment. The product portfolio of company in Computed Tomography includes Revolution Frontier, Revolution EVO, Revolution CT, Revolution HD, Optima CT540, and others. Choosing one specific niche and making considerable investments in R&D as well as advertising is one of the key strategies of GE.

Spectral Computed Tomography (CT) Market - Regional analysis

Geographically, America continues to dominate the global spectral computed tomography market owing to presence of huge patients suffering from the cardiovascular diseases, cancer and orthopedic diseases. According to Centers for Disease Control and Prevention, More than half of the total America population has acute or chronic cardiovascular diseases. Furthermore, rising geriatric population, and well-developed healthcare sector have contributed in the growth of the market. Europe accounts for the second largest market, which is followed by Asia Pacific. Asia Pacific is the fastest growing market owing to the presence of developing countries like India and China. The presence of a huge population and opportunities boosts the growth of the market. The Middle East & Africa owns the least share in the market.

Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/1026

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.